Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Annals of Translational Medicine|May 14, 2021
Inhibition of bone morphogenetic protein receptor 2 suppresses pancreatic ductal adenocarcinoma growth by regulating GRB2/PI3K/AKT axisYazhou Wang, Huahu Guo, Zhengkui Zhang, et al.
Scientific Reports|January 14, 2017
In vivo response of AZ31 alloy as biliary stents: a 6 months evaluation in rabbitsYang Liu, Shengmin Zheng, Nan Li, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|July 4, 2018
Programmed Death Receptor 1 (PD1) Knockout and Human Telomerase Reverse Transcriptase (hTERT) Transduction Can Enhance Persistence and Antitumor Efficacy of Cytokine-Induced Killer Cells Against Hepatocellular CarcinomaKanghua Huang, Bowen Sun, Nan Luo, et al.
Cancer Letters|June 26, 2020
Pancreatic stellate cells derived exosomal miR-5703 promotes pancreatic cancer by downregulating CMTM4 and activating PI3K/Akt pathwayMingzhe Li, Huahu Guo, Qi Wang, et al.
Biochemical and Biophysical Research Communications|September 25, 2016
Overexpression of SOX18 correlates with accelerated cell growth and poor prognosis in human pancreatic ductal adenocarcinomaYazhou Wang, Huahu Guo, Dafang Zhang, et al.
BMC Gastroenterology|April 17, 2025
MAFLD mediates the association between CHR and gallstones in the U.S. adults: evidence from NHANES 2021-2023Xin Feng, Xiangyu Song, Xi'an Yang, et al.
Ebiomedicine|April 5, 2021
Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progressionKai Chen, Qi Wang, Mingzhe Li, et al.
Frontiers in Bioscience (Landmark Edition)|May 30, 2024
A Predictive Model Based on the FBXO Family Reveals the Significance of Cyclin F in Hepatocellular CarcinomaDute Gao, Suxin Li, Huahu Guo, et al.
Clinical Epigenetics|June 26, 2019
Comprehensive DNA methylation analysis of tissue of origin of plasma cell-free DNA by methylated CpG tandem amplification and sequencing (MCTA-Seq)Xiaomeng Liu, Jie Ren, Nan Luo, et al.
Cancer Letters|June 13, 2017
BRM/SMARCA2 promotes the proliferation and chemoresistance of pancreatic cancer cells by targeting JAK2/STAT3 signalingZhengkui Zhang, Feng Wang, Chong Du, et al.
Pageof 3